A study published in the International Journal of Molecular Sciences examines how researchers are investigating specific biomarkers — ranging from visual contrast sensitivity testing to transcriptomic analysis — as potential tools to help differentiate between Chronic Inflammatory Response Syndrome (CIRS), a condition studied by researchers, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Research suggests that accurate differentiation between these two conditions may be important because they appear to involve different physiological mechanisms. This research adds to a field where researchers continue to seek improved diagnostic clarity for both patients and providers. Note: This account has not been independently verified by The Mold Report.